Everest Organics Ltd.

As of June 30, 2026, Everest Organics Ltd. carries a market capitalization of 2.43B, placing it among publicly traded companies globally. Its enterprise value stands at 2.43B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Everest Organics Ltd. has 9.71M shares outstanding.

As of June 30, 2026, Everest Organics Ltd. trades at a trailing price-to-earnings ratio of 46.15.

As of June 30, 2026, Everest Organics Ltd. trades at an EV/EBITDA multiple of 12.32 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.27 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 18.47 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 2.43B versus a market cap of 2.43B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 5.69M in revenue per employee across its workforce of 335.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Everest Organics Ltd. recorded 21.56M in income tax expense. That works out to an effective tax rate of 29.09, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 74.11M, leaving 52.55M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Everest Organics Ltd.'s stock has declined approximately 40.42% over the past 52 weeks. The 50-day moving average sits at 260.42, while the 200-day moving average is 301.51.

Over the twelve months ended June 30, 2026, Everest Organics Ltd. generated 1.91B in revenue and converted that into 52.55M in net income, yielding earnings per share of 5.42. EBITDA reached 197.01M, while operating income came in at 131.45M.

Over the twelve months ended June 30, 2026, Everest Organics Ltd. posted a gross margin of 37.82, reflecting its pricing power and cost economics. The operating margin of 6.89 and net profit margin of 2.75 provide insight into operational efficiency.